The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-Methoxyphenyl)-4-(6-(4-(4-methylpiperazin-1-yl)-phenyl)thieno[2,3-d]pyrimidin-4-yl)piperazine-1-carboxamide ID: ALA4878907
PubChem CID: 164631070
Max Phase: Preclinical
Molecular Formula: C29H33N7O2S
Molecular Weight: 543.70
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccccc1NC(=O)N1CCN(c2ncnc3sc(-c4ccc(N5CCN(C)CC5)cc4)cc23)CC1
Standard InChI: InChI=1S/C29H33N7O2S/c1-33-11-13-34(14-12-33)22-9-7-21(8-10-22)26-19-23-27(30-20-31-28(23)39-26)35-15-17-36(18-16-35)29(37)32-24-5-3-4-6-25(24)38-2/h3-10,19-20H,11-18H2,1-2H3,(H,32,37)
Standard InChI Key: DIRRBMPXJFFIFQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 44 0 0 0 0 0 0 0 0999 V2000
1.9769 -2.8602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2712 -3.2729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2712 -4.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9806 -4.5028 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6900 -4.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6900 -3.2729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9806 -5.3233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2667 -5.7313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2667 -6.5518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9787 -6.9654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6898 -6.5461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6898 -5.7291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4652 -5.4724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9478 -6.1307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4746 -6.7918 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.7660 -6.1307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1832 -6.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0037 -6.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4081 -6.1163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9900 -5.4051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1708 -5.4051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2252 -6.1080 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6352 -6.8112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4488 -6.8049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8541 -6.0948 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4395 -5.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6197 -5.3942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6712 -6.0897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9751 -2.0430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6819 -1.6328 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2665 -1.6360 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.3905 -2.0398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3875 -2.8571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0953 -3.2641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8031 -2.8538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7986 -2.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0903 -1.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0849 -0.8120 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7899 -0.3987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 1 1 0
4 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
12 11 2 0
12 7 1 0
13 12 1 0
14 13 2 0
15 14 1 0
11 15 1 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
1 29 1 0
29 30 1 0
29 31 2 0
30 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
37 38 1 0
38 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 543.70Molecular Weight (Monoisotopic): 543.2416AlogP: 4.47#Rotatable Bonds: 5Polar Surface Area: 77.07Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.87CX Basic pKa: 7.84CX LogP: 4.42CX LogD: 3.84Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.40Np Likeness Score: -1.85
References 1. Li Y, Yang G, Zhang J, Tang P, Yang C, Wang G, Chen J, Liu J, Zhang L, Ouyang L.. (2021) Discovery, Synthesis, and Evaluation of Highly Selective Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) Inhibitor for the Potential Treatment of Metastatic Triple-Negative Breast Cancer., 64 (16.0): [PMID:34351741 ] [10.1021/acs.jmedchem.1c00678 ]